Medical Device News Magazine

IVF Myths That Need to Be Busted for Good

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Infertility is a common problem in both men and women today. And thanks to the advancement of medical science, in-vitro fertilization (IVF) is one common solution to ensure that an infertile couple is still able to give birth to a healthy baby.

In Australia, 1 in 20 babies is born out of IVF, which is a pretty common procedure. However, many misconceptions and social stigmas are attached to assisted reproductive techniques (ART), of which IVF is a part.

In this article, let’s look at some common IVF myths that need to be busted for good.

  1. Myth: IVF babies have abnormalities.

Fact: IVF babies do not have any abnormalities. Even if they do, it’s not because they’re born through IVF.

It can be caused due to genetic problems in either or both parents, but not due to technology. In many cases, males experiencing a low sperm count might suffer from genetic problems, which might be passed down to the children.

Females possessing faulty genes can give birth to babies with genetic disorders, even if they were conceived through natural means.

  1. Myth: IVF is only meant for infertile couples

 Fact: This myth is only partially right. While most infertile couples choose to undergo an IVF process to have their baby, it’s not simply limited to infertility.

As mentioned, parents with genetic disorders can also choose to have a baby through IVF if they feel their diseases will affect their health and lifespan.

Here, only the healthy embryos and sperm from the parents are collected and grown in a petri dish. Even same-sex couples can choose to get pregnant from one set of sperm or eggs.

  1. Myth: IVF can be done at any age

Fact: Unfortunately, IVF is age-restricted. This is because the procedure requires healthy eggs and sperm from biological parents or donors.

But women only have a limited number of eggs, unlike men, who can produce sperm throughout their lives. And after a certain age, the eggs start to deteriorate in quality.

Moreover, even if the fertilized embryo is healthy, the woman’s uterus might not be strong enough to complete the nine-month gestation period.

  1. Myth: IVF always causes multiple births

Fact: Yes, IVF can lead to multiple births, but that isn’t always the case. This myth started to circulate in society because earlier, doctors used to develop multiple embryos in their labs to ensure that at least one managed to survive.

But since medicine and technology have developed quite a bit today, there’s no need to always transfer multiple embryos to the mother’s uterus.

Most IVF clinics will transfer only one healthy embryo at a time to increase the success rate.

  1. Myth: IVF takes a long time to be successful

Fact: The success of an IVF procedure depends on many different factors, starting from the mother’s age to the quality and quantity of the sperm and eggs donated.

Even environmental factors, namely the environment of the mother’s uterus and fallopian tubes, play an important role.

In fact, almost 70% of parents have said that their IVF procedures were successful right on the first try. Though it’s difficult to assume, the success rate of each procedure is more subjective.

  1. Myth: IVF is the only way out for infertile couple

Fact: No, IVF is one of the many procedures available for infertile couples. Most doctors recommend that interested parents go through all sorts of medical evaluations before choosing IVF.

Since this is a time-consuming and slightly expensive process, many simpler methods are available.

For example, a couple might benefit from simpler processes, such as undergoing a small surgery to correct any physiological conditions or taking medicines to make their hormones more efficient,

  1. Myth: IVF babies are different from natural-birth babies

Fact: This is probably the most common myth associated with IVF and the primary reason why so many couples are afraid to undergo the process.

Contrary to this, IVF babies are the same as babies conceived naturally in the mother’s womb.

Even though the process of conception is different, it doesn’t mean that IVF parents can’t enjoy happy parenthood. Biologically speaking, the child is theirs and can have a great life ahead.

Over to you…

These are some of the most common myths and scientific facts related to IVF. If you and your partner feel that it’s time for you to consult a specialist, don’t hesitate to book an appointment.

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”